TotalMarketCap

Clearmind Medicine

CMNDNasdaq CanadaHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$2.897 M

$5.71 -4.71%

Close of 6 Nov 2026

As of 6 Nov 2026, Clearmind Medicine (CMND) has a market capitalization of $2.90M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

158,076

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #471Mustang BioMBIO$2.99M
  2. #472Kala BioKALA$2.95M
  3. #473Clearmind MedicineCMND$2.90M
  4. #474Jupiter NeurosciencesJUNS$2.88M
  5. #475NeuroSense TherapeuticsNRSN$2.75M

What if Clearmind Medicine were worth as much as…

Open the what-if tool →

Gold $28.2T

$55,649,684

Per share 9,746,004× higher

Bitcoin $1.53T

$3,011,108

Per share 527,339× higher

Apple $5.02T

$9,885,185

Per share 1,731,206× higher

Or at a round number

$5.00M$10.0M$20.0M$50.0M

Where these numbers come from

Share counts and financials for Clearmind Medicine are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.